evenfolioETF Details
ProShares·Leveraged Equity·BIB · Nasdaq
ProShares Ultra Nasdaq Biotechnology (BIB)
- Price
- $120.53
- —30 Oct 2026
- Assets
- $96.8M
- Total net assets
- Expense ratio
- 0.95%
- Category 0.00%
- Yield
- 0.19%
- Trailing distributions
- 1Y return
- 73.1%+85.6%
- Category -12.6%
- 3Y CAGR
- 44.4%+13.0%
- Category 31.4%
- 5Y CAGR
- 6.4%+3.6%
- Category 2.8%
Loading NAV history…
ProShares Ultra Nasdaq Biotechnology
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +4.4% | +24.9% | +51.2% | +51.2% | +73.1% | +44.4% | +6.4% | +12.2% | +18.5% |
| Leveraged Equity average | -23.8% | -14.7% | -17.9% | -7.1% | -12.6% | 31.4% | 2.8% | 9.4% | -20.3% |
| Difference | +28.2% | +39.5% | +69.1% | +58.3% | +85.6% | +13.0% | +3.6% | +2.8% | +38.7% |
Holdings
The 8 largest positions make up 39.0% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| IQMM | ProShares GENIUS Money Market ETF | 17.56% |
| GILD | Gilead Sciences Inc | 4.45% |
| AMGN | Amgen Inc | 4.29% |
| VRTX | Vertex Pharmaceuticals Inc | 4.20% |
| MRNA | Moderna Inc | 2.75% |
| REGN | Regeneron Pharmaceuticals Inc | 2.75% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.58% |
| ILMN | Illumina Inc | 1.48% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 5.4
- P/S
- 6.7
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks65.8%
- Cash24.7%
- Other9.6%
Credit quality
Share of the bonds by rating.
- US government17.5%
ETF details
- Issuer
- ProShares
- Category
- Equity · Leveraged Equity
- Ticker
- BIB
- Exchange
- Nasdaq
- Inception
- 6 Apr 2010 (16.6 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.95% (category 0.00%)
- Holdings turnover
- 29%
- Distribution yield
- 0.19%
- Beta, 3 years
- 1.12
- Total net assets
- $96.8M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other leveraged equity ETFs
Other ETFs in the Leveraged Equity category.
- RXL · ProShares Ultra Health CareProShares · $96.6M · ER 0.95%5Y 7.1%
- APPX · Tradr 2X Long APP Daily ETFAXS · $96.1M · ER 1.36%
- SPCF · ProShares Ultra SpaceX ETFProShares · $94.1M · ER 0.95%
- LLYX · Defiance Daily Target 2X Long LLY ETFDefiance ETFs LLC · $88.6M · ER 1.49%
- LINT · Direxion Daily INTC Bull 2X ETFDirexion Funds · $88.2M · ER 0.97%
- WEBL · Direxion Daily Dow Jones Internet Bull 3X ETFDirexion Funds · $87.6M · ER 0.96%5Y -23.6%